Schedule 13G ownership disclosure

Tonix Pharmaceuticals Holding Corp.

Security class unavailable · CUSIP: 890260508

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
296,727
Percent of class
9.1200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-19-000047
Form type
SC 13G/A
Filer
SABBY MANAGEMENT, LLC
CIK
CIK 1535610
Filed
Jan 07, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub